-
Aspirin, Higher Doses No More Effective, Risky; Subclinical Hypothyroidism Treatment Benefits; FDA approvals
-
-
The immune response to HIV exerts a selective pressure, just as do antiretroviral drugs. Cytotoxic T lymphocytes (CTL) that recognize HLA class I-restricted viral epitopes expressed on the surface of infected cells exert a pressure on these epitopes.
-
A typical mycobacteria are the most common cause of chronic cervicofacial lymphadenitis in children.
-
Why do people die with influenza? three new articles seemingly disparate relate to this age-old question.
-
Cases of coccidioidomycosis in the desert states have increased substantially in the past few years, but Arizona has been the hardest hit, with a record number of 5493 cases in 2006.
-
Although the addition of PCI to optimal medical therapy in patients with chronic stable CHD reduced the prevalence of angina, it did not reduce the long-term rates of death, nonfatal myocardial infarctions and hospitalizations for acute coronary syndromes.
-
The FDA has approved the first of a new class of antibiotics for the topical treatment of impetigo. Retapamulin belongs to a class of agents called pleuromutilins.
-
Unless prophylaxed, most post-stroke patients with hemiplegia develop deep venous thrombosis (DVT), and as many as 20% sustain pulmonary embolism (PE).
-
A randomized controlled trial of 281 men with BPH showed that once daily Tadalafil (Cialis) 20 mg improved lower urinary tract symptoms compared with placebo.
